Salarius Pharmaceuticals SLRX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 0.75 | 0 | -217.28 | -2 | -63.78 | 2 |
| 2024Q4 | 1.84 | 2 | -65.99 | -1 | -42.55 | 3 |
| 2024Q3 | 1.44 | 3 | -36.68 | -1 | -26.22 | 4 |
| 2024Q2 | 2.38 | 2 | -47.27 | -1 | -33.75 | 4 |
| 2024Q1 | 4.23 | 4 | -38.38 | -2 | -29.90 | 5 |
| 2023Q4 | 5.20 | 5 | -15.51 | -1 | -11.77 | 7 |
| 2023Q3 | 5.26 | 6 | -33.70 | -2 | -23.88 | 8 |
| 2023Q2 | 11.92 | 8 | -55.49 | -4 | -35.07 | 12 |
| 2023Q1 | 15.28 | 6 | -67.00 | -5 | -43.24 | 10 |
| 2022Q4 | 12.24 | 10 | -47.20 | -6 | -37.07 | 15 |
| 2022Q3 | 39.00 | 17 | -60.67 | -14 | -53.99 | 20 |
| 2022Q2 | 42.00 | 31 | -14.67 | -5 | -13.64 | 34 |
| 2022Q1 | 79.62 | 33 | -16.94 | -6 | -16.00 | 36 |
| 2021Q4 | 99.12 | 39 | -10.09 | -4 | -9.65 | 41 |
| 2021Q3 | 204.00 | 43 | -8.45 | -4 | -8.15 | 44 |
| 2021Q2 | 212.00 | 46 | -6.50 | -3 | -6.26 | 47 |
| 2021Q1 | 296.00 | 49 | -5.22 | -2 | -4.89 | 51 |
| 2020Q4 | 182.00 | 22 | -8.27 | -2 | -7.37 | 25 |
| 2020Q3 | 168.78 | 21 | -9.17 | -2 | -8.25 | 23 |
| 2020Q2 | 264.00 | 17 | -10.24 | -2 | -9.24 | 19 |